Impact of Oncology Drug Shortages on Chemotherapy Treatment

Affiliations

PMID: 30739322
PMCID: PMC6663594 (available on 2020-08-01)
DOI: 10.1002/cpt.1390

Abstract

Prescription drug shortages began to increase markedly in the mid-2000s, including sterile injectable products such as chemotherapy drugs. Using Medicare claims linked to Surveillance Epidemiology and End Results (SEER), we examined outpatient chemotherapy use during shortage periods relative to the months before and after a shortage for newly diagnosed patients with breast, colorectal, leukemia, lung, lymphoma, ovarian, or pancreatic cancer (N = 182,470). For most drugs, we found little impact of shortages on either the fraction of patients receiving that drug or the quantity provided. In some cases, we found declines in utilization: 4% for doxorubicin and fluorouracil; 2.9% for oxaliplatin; and about 1% for cytarabine, dacarbazine, and leuprolide. Although shortages for a few drugs resulted in substantial reductions in use, in most cases, they resulted in little to no reduction. We discuss potential explanations for these counterintuitive findings, including potential limitations of current drug shortage reporting methods.

Conflict of interest statement

Conflicts of Interest: The authors declared no competing interests for this work.

Similar articles

The Impact of Chemotherapy Shortages on COG and Local Clinical Trials: A Report From the Children's Oncology Group
E G Salazar et al. Pediatr Blood Cancer 62 (6), 940-4. Jun 2015. PMID 25704486.
Chemotherapy shortages remain widespread across institutions, hinder clinical trials, and may contribute to adverse events in children with cancer. The increased frequenc …
Drug Shortages: Implications for Medical Toxicology
M Mazer-Amirshahi et al. Clin Toxicol (Phila) 53 (6), 519-24. Jul 2015. PMID 25951876.
Drug shortages affected a substantial number of critical agents used in the management of poisoned patients. Shortages were often of long duration and for drugs without a …
The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States
R Gupta et al. J Manag Care Spec Pharm 23 (10), 1066-1076. Oct 2017. PMID 28944731.
The UDI was associated with higher drug prices and more frequent drug shortages when compared with the period before UDI action, while the approval process for these drug …
US Propofol Drug Shortages: A Review of the Problem and Stakeholder Analysis
C Hvisdas et al. Am Health Drug Benefits 6 (4), 171-5. May 2013. PMID 24991355. - Review
The shortage of propofol significantly impacted the delivery of care in the United States in 2009, and various stakeholders are working to increase the existing supply of …
Development of Biosimilars in an Era of Oncologic Drug Shortages
E Li et al. Drug Des Devel Ther 9, 3247-55. 2015. PMID 26150698. - Review
Acute and chronic shortages of various pharmaceuticals and particularly of sterile injectable products are being reported on a global scale, prompting evaluation of more …